News Related News

BGene Genetics announces the acquisition of CAD4Bio

Grenoble, 07/17/2017 : BGene Genetics, a company specialised in synthetic biology, has acquired CAD4Bio, a company specialised in the development of software dedicated to molecular biology with whom it has been collaborating for 3 years. This acquisition forms part of BGene [...]

By | July 19th, 2017|CAD Tools, Industry Providers, News, Press Releases|

Amyris Enters Into First Product Development and Production Agreement With Royal DSM For Food and Nutrition Molecule

EMERYVILLE, Calif., July 17, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announces that it has entered into its first product development and production agreement with Koninklijke DSM N.V. (Royal DSM) (AEX:DSM.AS), the global science-based company [...]

By | July 17th, 2017|Consumer Products & Manufacturing, Food, News, Press Releases|

Oxitec Launching Friendly™ Aedes Project in Juiz de Fora, Brazil

OXFORD, England, July 11, 2017 /PRNewswire/ -- Oxitec Ltd., a wholly-owned subsidiary of Intrexon Corporation (NYSE: XON), today announced Oxitec do Brasil has signed a contract to launch the Friendly™ Aedes Project in Juiz de Fora, Brazil. Juiz de Fora becomes the second [...]

By | July 17th, 2017|Agriculture, Crop Protection, News, Press Releases|

CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration

CAMBRIDGE, Mass. and BASEL, Switzerland, July 10, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T cell therapies to treat [...]

By | July 17th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Calyxt Announces Proposed Initial Public Offering of $100.0 Million

St. Paul, Minn. and New York, NY, July 10, 2017 – Cellectis S.A. (Alternext: ALCLS; Nasdaq: CLLS) and Calyxt, Inc. announced today that Calyxt has commenced a proposed initial public offering of 6,060,606 shares of Calyxt’s common stock pursuant to a [...]

By | July 17th, 2017|News|

US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology

STELLENBOSCH, South Africa, July 12, 2017 /PRNewswire/ -- AzarGen Biotechnologies (Pty) Ltd (Stellenbosch, South Africa) announced that it has received grant status for the patent application: SYNTHETIC PROMOTER CONSTRUCT FOR TRANSGENE EXPRESSION (US9670497) from the US Patent office. With special emphasis on the genetic [...]

By | July 17th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|